Growing global burden of DKA
Global healthcare company Abbott, has announced new data that reveals a growing global burden of diabetic ketoacidosis (DKA). The findings also show significant gaps in
Global healthcare company Abbott, has announced new data that reveals a growing global burden of diabetic ketoacidosis (DKA). The findings also show significant gaps in
Some readers may remember Abbott’s FreeDM2 randomised controlled trial (RCT). We ran a couple of recruitment articles in the magazine, so some readers may have
The UK Health Security Agency (UKHSA) and Medicines and Healthcare products Regulatory Agency (MHRA) are reminding the public not to use some non-sterile alcohol-free wipe
We have loads and loads of NEWS and an awful lot of it is about KIT. From p.4 read about such items as the first
Well, this is a rather fun edition to see you through the rest of the summer. We’ve got a new comic character from Marvel on
Within the News pages, we cover how an existing HIV drug may be a useful and affordable treatment for DMO (diabetic macular oedema). We have
There’s been a jaw-dropping £100m historic pledge to end T1D, with Diabetes UK and Breakthrough T1D in the US being recipients. There’s also Breakthrough T1D
Being a lab rat or a guinea pig does not sound all that attractive, at least to most of us. However, at the same time
Spring in the air means a spring in your step – at least it does for me. I’m using that as my excuse to go
This issue feels a little heavy, as a few topics are tough ones, about people feeling stigma, shame or simply experiencing a build-up of comments